[go: up one dir, main page]

UY37222A - PROCEDIMIENTO PARA LA PREPARACIÓN DE DERIVADOS DE 1-FENILO-1,2,4-TRIAZOL SUSTITUIDOS POR 5-HIdroxIalQUILO - Google Patents

PROCEDIMIENTO PARA LA PREPARACIÓN DE DERIVADOS DE 1-FENILO-1,2,4-TRIAZOL SUSTITUIDOS POR 5-HIdroxIalQUILO

Info

Publication number
UY37222A
UY37222A UY0001037222A UY37222A UY37222A UY 37222 A UY37222 A UY 37222A UY 0001037222 A UY0001037222 A UY 0001037222A UY 37222 A UY37222 A UY 37222A UY 37222 A UY37222 A UY 37222A
Authority
UY
Uruguay
Prior art keywords
preparation
triazol
phenyl
derivatives
hydroxyalquyl
Prior art date
Application number
UY0001037222A
Other languages
English (en)
Inventor
Kersten Matthias Gericke Dr
Philipp Rubenbauer Dr
Heiko Schirmer Dr
Thomas Neubauer Dr
Marie-Pierre Collin Dr
SÜßIMEIER Frank
Chantal Fürstner Dr
Hans-Christian Militzer Dr
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of UY37222A publication Critical patent/UY37222A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente solicitud se refiere a un procedimiento novedoso y mejorado para la preparación de derivados de 5-(hidroxialquilo)-1-fenilo-1,2,4-triazol de la fórmula (I) en la que R1A y R1B se seleccionan independientemente del grupo que consiste en hidrógeno, flúor, cloro, metilo, monofluormetilo, difluormetilo, trifluormetilo, etilo, metoxi, difluormetoxi y trifluormetoxi, nuevas fases previas para su preparación y la preparación y el uso de la modificación cristalina I de (5-(4- 10 clorofenil)-2-({1-(3-clorofenil)-5-[(1S)-1-hidroxietil]-1H-1,2,4-triazol-3-ilo}metilo)-4-[(2S)-3,3,3-trifluor- 2-hidroxipropil]-2,4-dihidro-3H-1,2,4-triazol-3-ona de la fórmula (I-A-1).
UY0001037222A 2016-05-03 2017-05-02 PROCEDIMIENTO PARA LA PREPARACIÓN DE DERIVADOS DE 1-FENILO-1,2,4-TRIAZOL SUSTITUIDOS POR 5-HIdroxIalQUILO UY37222A (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP16168163 2016-05-03
EP16168165 2016-05-03
EP16168166 2016-05-03
EP16168172 2016-05-03
EP16168169 2016-05-03
EP17160086 2017-03-09

Publications (1)

Publication Number Publication Date
UY37222A true UY37222A (es) 2017-11-30

Family

ID=58633014

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001037222A UY37222A (es) 2016-05-03 2017-05-02 PROCEDIMIENTO PARA LA PREPARACIÓN DE DERIVADOS DE 1-FENILO-1,2,4-TRIAZOL SUSTITUIDOS POR 5-HIdroxIalQUILO

Country Status (18)

Country Link
US (2) US10703742B2 (es)
EP (1) EP3452467A1 (es)
JP (2) JP6921863B2 (es)
KR (1) KR20190003536A (es)
CN (2) CN109071500B (es)
AU (2) AU2017259872B2 (es)
BR (1) BR112018072528A2 (es)
CA (1) CA3022789A1 (es)
CL (1) CL2018003107A1 (es)
CO (1) CO2018011948A2 (es)
IL (1) IL262534B (es)
MX (2) MX2020010365A (es)
PE (1) PE20190202A1 (es)
RU (1) RU2742885C2 (es)
SG (1) SG11201809672YA (es)
TW (1) TWI755393B (es)
UY (1) UY37222A (es)
WO (1) WO2017191104A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201809672YA (en) * 2016-05-03 2018-11-29 Bayer Pharma AG Process For Preparing 5-Hydroxyalkyl-Substituted 1-Phenyl-1,2,4-Triazole Derivatives
US9988367B2 (en) * 2016-05-03 2018-06-05 Bayer Pharma Aktiengesellschaft Amide-substituted pyridinyltriazole derivatives and uses thereof
US10800746B2 (en) * 2016-05-03 2020-10-13 Bayer Pharma Aktiengesellschaft Oxoalkyl-substituted phenyltriazole derivatives and uses thereof
WO2021259852A1 (en) 2020-06-25 2021-12-30 Bayer Aktiengesellschaft Process for preparing 5-(alkoxycarbonyl)-and 5-(carboxamide)-1-aryl-1,2,4-triazole derivatives

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2653332A1 (en) * 2006-05-25 2007-12-06 Synta Pharmaceuticals Corp. Triazole compounds that modulate hsp90 activity
US20110237528A1 (en) * 2008-09-19 2011-09-29 Institute For Oneworld Health Compositions and methods comprising imidazole and triazole derivatives
DE102010001064A1 (de) 2009-03-18 2010-09-23 Bayer Schering Pharma Aktiengesellschaft Substituierte 2-Acetamido-5-Aryl-1,2,4-triazolone und deren Verwendung
WO2011104322A1 (de) * 2010-02-27 2011-09-01 Bayer Pharma Aktiengesellschaft Bis-arylverknüpfte aryltriazolone und ihre verwendung
BR112014027564B1 (pt) * 2012-05-08 2022-05-03 Bayer Pharma Aktiengellschaft Método para a preparação de compostos de triazol
SG11201703199UA (en) * 2014-11-03 2017-05-30 Bayer Pharma AG Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereof
SG11201809672YA (en) * 2016-05-03 2018-11-29 Bayer Pharma AG Process For Preparing 5-Hydroxyalkyl-Substituted 1-Phenyl-1,2,4-Triazole Derivatives
US9988367B2 (en) * 2016-05-03 2018-06-05 Bayer Pharma Aktiengesellschaft Amide-substituted pyridinyltriazole derivatives and uses thereof
US10800746B2 (en) * 2016-05-03 2020-10-13 Bayer Pharma Aktiengesellschaft Oxoalkyl-substituted phenyltriazole derivatives and uses thereof

Also Published As

Publication number Publication date
PE20190202A1 (es) 2019-02-05
EP3452467A1 (de) 2019-03-13
RU2742885C2 (ru) 2021-02-11
BR112018072528A2 (pt) 2019-03-26
AU2017259872A1 (en) 2018-11-22
CL2018003107A1 (es) 2019-02-22
RU2018142264A3 (es) 2020-08-19
TW201815782A (zh) 2018-05-01
RU2018142264A (ru) 2020-06-03
CO2018011948A2 (es) 2018-11-22
MX2018013336A (es) 2019-05-09
TWI755393B (zh) 2022-02-21
CN113105403A (zh) 2021-07-13
JP6921863B2 (ja) 2021-08-18
AU2017259872B2 (en) 2021-06-24
SG11201809672YA (en) 2018-11-29
JP2019514948A (ja) 2019-06-06
CN109071500A (zh) 2018-12-21
CA3022789A1 (en) 2017-11-09
AU2021236502A1 (en) 2021-10-21
JP2021143193A (ja) 2021-09-24
MX379555B (es) 2025-03-11
US20200299271A1 (en) 2020-09-24
IL262534A (en) 2018-12-31
CN109071500B (zh) 2021-05-18
IL262534B (en) 2021-04-29
MX2020010365A (es) 2022-04-06
US10703742B2 (en) 2020-07-07
WO2017191104A1 (de) 2017-11-09
US20190144431A1 (en) 2019-05-16
KR20190003536A (ko) 2019-01-09

Similar Documents

Publication Publication Date Title
CO2018011948A2 (es) Procedimiento para la preparación de derivados de 1-fenilo-1,2,4- triazol sustituidos por 5-hidroxialquilo
AR102487A1 (es) Derivados de feniltriazol sustituido con hidroxialquilo y sus usos
CL2014000384A1 (es) Compuestos fungicidas de 1-(2-(2-halo-4-(4-halogen-fenoxi)-fenil)-2-alcoxi-2-alquinil/alquenil-etil)-1h-(1,2,4) triazol sustituidos; proceso para preparar dichos compuestos; composiciones agroquímicas.
CL2014000201A1 (es) Compuestos fungicidas de 1-(2-(2-halo-4-(4-halogen-fenoxi)-fenil)-2-aluiniloxi-etil)-1h-(1,2,4)triazol sustituidos; procesos para preparar dichos compuestos; uso de dichos compuestos para combatir hongos fitopatógenos.
CL2014000125A1 (es) Compuesto fungicidas de 1-(2-(2-halo-4-(4-halogen-fenoxi)-fenil)-2-etoxi-etil)-1h-(1,2,4)triazol sustituidos; procesos para preparar dichos compuestos; uso de dichos compuestos para combatir hongos fitopatógenos.
EP4295852A3 (en) Piperidine derivatives as inhibitors of cyclin dependent kinase 7 (cdk7)
CA2727528A1 (en) Heme-oxygenase inhibitors and use of the same in the treatment of cancer and diseases of the central nervous system
AR104695A1 (es) Compuestos fungicidas
PH12016501935A1 (en) Inhibitors of cyclin-dependent kinase 7 (cdk7)
CL2013003672A1 (es) Compuestos fungicidas de 1-(2-(2-halo-4-(4-halogen-fenoxi)-fenil)-2-alcoxi-2-ciclil-etil)-1h-(1,2,4)triazol sustituidos; procesos para preparar dichos compuestos; composicion agroquimica que la comprende; uso para combatir hongos fitopatógenos.
IL281196A (en) Process for the preparation of methyl 6-(4,2-dichlorophenyl)-5-[4-[(S3)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-9,8-dihydro-H7-benzo[ 7]Anolene-2-carboxylate
PE20190345A1 (es) Combinaciones de compuestos activos
BRPI0606463A2 (pt) derivados triazol substituìdos com antagonistas de oxitocina
ZA201100026B (en) 4-(pyridin-4-yl)-1h-(1,3,5)triazin-2-one derivatives as gsk3-beta inhibitors for the treatment of neurodegenerative diseases
CL2008001074A1 (es) Uso de compuestos de triazol, antagonistas de smo para tratar cancer.
NZ627113A (en) Substituted pyrimidine compounds and their use as syk inhibitors
PH12015502088A1 (en) Novel compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazole orotate formulations
WO2007013096A8 (en) Improved process for the preparation of 2r, 3s-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl) butan-2-ol (voriconazole)
JP2016520635A5 (es)
MY184577A (en) Method for the preparation of triazole compounds
NI202000030A (es) Profármacos de derivados de triazol sustituido y sus usos
TN2018000126A1 (en) 1,3,4-thiadiazole compounds and their use in treating cancer
JP2016520636A5 (es)
EP3233079A4 (en) (s)-n-(3-(6-isopropoxypyridin-3-yl)-1h-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2h)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations
AR076372A1 (es) Derivados de etil-tiotriazol, composiciones farmaceuticas que los comprenden, intermediarios para su sintesis y su uso en el tratamiento de trastornos mediados por mglur5

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20230612